Research Shows Rising Appendix Cancer Rates Among Millennials and Gen X

A recent study has revealed that a rare type of cancer is becoming more prevalent among millennials and Generation X. Specifically, for those born between 1976 and 1984, diagnoses of appendix cancer in the U.S. have tripled, particularly for individuals born between 1981 and 1989.

This study was published in the Internal Medicine Chronicles on a Monday.

Common Menopause Medications May Prevent Breast Cancer

Researchers at Vanderbilt University Medical Center analyzed data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program to arrive at these conclusions.

“Along with the alarming statistic that one in three appendix cancer patients is diagnosed before the age of 50, these rates amplify the need for timely recognition of symptoms associated with appendix cancer,” a representative from the university commented.

FDA Approves First AI Tools to Predict Breast Cancer Risk

According to the National Cancer Institute, appendix cancer is rare, affecting about 1 in 200 people annually in the United States. Still, doctors stress that it’s crucial to consult a physician when symptoms arise.

“Timely diagnosis is essential in managing appendix cancer,” stated Holowatyj, emphasizing the need to understand what is driving this troubling trend.

Appendix cancer forms in the appendix, a small organ located in the lower right abdomen. There are two primary types of this cancer: epithelial appendix cancers, which arise from the inner layer of the appendix, and neuroendocrine appendix cancers, which develop from neuroendocrine tumors.

Most individuals are unaware of symptoms in the early stages. However, as the cancer progresses, symptoms can include abdominal pain, nausea, vomiting, bloating, and sometimes an abdominal mass.

The survival rate for appendix cancer within five years can vary significantly, ranging from 10% to 63%. Treatments typically involve surgical removal of the appendix and possibly other affected organs, along with chemotherapy aimed at eliminating metastatic cancer cells.

Researchers aim to elevate awareness among both the public and healthcare professionals. They emphasize that the growing incidence among younger people highlights a potential future burden of diseases, reinforcing the need for focused investigations into appendix adenocarcinoma.

Currently, there are no standard screening guidelines or recognized risk factors for appendix cancer.

This recent study was funded by the Appendix Cancer Pseudocytoma (ACPMP) Research Foundation and the National Institutes of Health.